Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains 
Thailand Inflation Remains Negative for 10th Straight Month in January 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks 
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
The US Food and Drug Administration (FDA) is testing prototypes for a new front-of-pack symbol demoting when a food or beverage can be deemed “healthy.”
The FDA is soliciting comments on several proposed symbols, which all bear the words “FDA” and “Healthy.” The symbols would be voluntarily available to marketers on products that meet FDA standards to be called “healthy.”
The action is separate from FDA’s efforts to redefine what’s “healthy,” which has been going on for years.
In the Federal Register notice, the FDA noted that its research in coming up with the symbol is not dependent on specific criteria for ‘healthy’” and therefore does not have to wait until there is a final, updated regulatory definition.
